a

Blade is a smooth and charming, visually stunning and very malleable and flexible

[social_icons type="circle_social" icon="fa-facebook" use_custom_size="yes" custom_size="14" custom_shape_size="17" link="https://www.facebook.com/" target="_blank" icon_margin="0 10px 0 0" icon_color="#ffffff" icon_hover_color="#ffffff" background_color="rgba(255,255,255,0.01)" background_hover_color="#21d279" border_width="2" border_color="#7d7d7d" border_hover_color="#21d279"][social_icons type="circle_social" icon="fa-twitter" use_custom_size="yes" custom_size="14" custom_shape_size="17" link="https://twitter.com/" target="_blank" icon_margin="0 10px 0 0" icon_color="#ffffff" icon_hover_color="#ffffff" background_color="rgba(255,255,255,0.01)" background_hover_color="#21d279" border_width="2" border_color="#7d7d7d" border_hover_color="#21d279"][social_icons type="circle_social" icon="fa-linkedin" use_custom_size="yes" custom_size="14" custom_shape_size="17" link="https://www.linkedin.com/" target="_blank" icon_margin="0 10px 0 0" icon_color="#ffffff" icon_hover_color="#ffffff" background_color="rgba(255,255,255,0.01)" background_hover_color="#21d279" border_width="2" border_color="#7d7d7d" border_hover_color="#21d279"] [vc_empty_space height="31px"] Copyright Qode Interactive 2017

Overdose

SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today conditional acceptance by the U.S. Food and Drug Administration (FDA) of the proposed brand name for the company’s high dose naloxone product candidate. The notification to the company from...